(Q41396680)

30 September 2017

1 reference

title

Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma (English)

1 reference

30 September 2017

Kyle RA

1

1 reference

30 September 2017

1 February 1997

1 reference

Hematology / Oncology Clinics of North America

30 September 2017

1 reference

30 September 2017

11

1 reference

30 September 2017

71-87

1 reference

30 September 2017

1

1 reference

A 20-year follow-up study of 64 subjects with M-components

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Mechanisms of bone lesions in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Solitary myeloma: clinical and prognostic features of a review of 114 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

The physiopathological significance of benign monoclonal gammopathy: a study of 64 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Evaluation of monoclonal gammopathies in the "well" elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Curability of solitary bone plasmacytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Solitary plasmacytoma of bone: clinical features, treatment and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Solitary plasmacytoma of bone: Mayo Clinic experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Plasmacytoma. Treatment results and conversion to myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Upper humeral cortical thickness as an indicator of osteopenia: diagnostic significance in solitary myeloma of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Monoclonal gammopathy of undetermined significance. Natural history in 241 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

'Benign' monoclonal gammopathy. A misnomer?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

"Benign" monoclonal gammopathy--after 20 to 35 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Monoclonal gammopathies in human aging: increased occurrence with age and correlation with health status

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Multiple myeloma or benign monoclonal gammopathy? A study of differential diagnostic criteria in 44 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Diagnostic value of the concentration of M-component in initial classification of monoclonal gammopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Magnetic resonance imaging in the staging of solitary plasmacytoma of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Monoclonal gammopathies in the adult population of Finistère, France

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Analysis of multidrug-resistance (MDR-1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

Interleukin-6 dependence of advanced malignant plasma cell dyscrasias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970416-0

7 January 2021

10.1016/S0889-8588(05)70416-0

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9081205